Role of src-suppressed C kinase substrate in rat pulmonary microvascular endothelial hyperpermeability stimulated by

Qing-Hai You1, Geng-Yun Sun, Nan Wang

  • 1Department of Respiratory Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.

Abstract

Insights

Src-suppressed C kinase substrate (SSeCKS) plays a role in inflammatory responses. This protein is involved in regulating endothelial cell permeability when exposed to inflammatory cytokines like interleukin-1β and tumor necrosis factor-α.

Area of Science:

  • Endothelial biology
  • Molecular and cellular physiology
  • Inflammation research

Background:

  • Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) are key inflammatory cytokines.
  • Endothelial barrier function is crucial for regulating microvascular permeability.
  • Src-suppressed C kinase substrate (SSeCKS) is a protein kinase substrate with poorly understood roles in endothelial cells.

Purpose of the Study:

  • To investigate the role of SSeCKS in rat pulmonary microvascular endothelial cells (RPMVEC) permeability.
  • To determine if SSeCKS is involved in the endothelial response to IL-1β and TNF-α.

Main Methods:

  • Gene and protein expression of SSeCKS analyzed using RT-PCR and immunoblotting.
  • Protein kinase C (PKC) signaling pathway activation assessed.
  • Transendothelial electrical resistance (TER) and FITC-dextran flux (P(d)) measured across RPMVEC monolayers.
  • SSeCKS function studied using small interfering RNA (siRNA) in RPMVEC.

Main Results:

  • IL-1β and TNF-α activated PKC signaling and upregulated SSeCKS expression in RPMVEC.
  • Depletion of SSeCKS attenuated cytokine-induced decreases in TER and increases in P(d).
  • PKC inhibitors reduced cytokine-induced hyperpermeability and SSeCKS expression.

Conclusions:

  • SSeCKS is implicated in the endothelial hyperpermeability triggered by IL-1β and TNF-α during inflammation.
  • SSeCKS is a mediator in the inflammatory pathway affecting endothelial barrier function.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...